Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit


ÖZDEMİR N., ÇELİKER A., KUŞKONMAZ B. B., ÇETİNKAYA F. D.

ISTANBUL JOURNAL OF PHARMACY, vol.51, no.1, pp.1-7, 2021 (ESCI) identifier

Abstract

Background and Aims: Many drugs with narrow therapeutic range and high toxicity risk are used in hematopoietic stem cell transplantation (HSCT) Units. The increase in the number of drugs raises the likelihood of interactions. This is particularly important in pediatric patients and may adversely affect the treatment process. In this study, we aimed to determine the potential drug interactions and to evaluate the clinical significance of them in terms of physician's and pharmacist's perceptions.